[
    [
        {
            "time": "",
            "original_text": "欧普康视2021年三季报点评：业绩符合我们预期，OK镜龙头地位持续巩固【东吴医药朱国广团队】",
            "features": {
                "keywords": [
                    "欧普康视",
                    "三季报",
                    "OK镜",
                    "龙头地位",
                    "业绩预期"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "欧普康视2021年三季报点评：业绩符合我们预期，OK镜龙头地位持续巩固【东吴医药朱国广团队】",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华鑫证券维持欧普康视推荐评级：终端需求良好，业绩符合预期",
            "features": {
                "keywords": [
                    "华鑫证券",
                    "欧普康视",
                    "推荐评级",
                    "终端需求",
                    "业绩预期"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华鑫证券维持欧普康视推荐评级：终端需求良好，业绩符合预期",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        }
    ]
]